ReviewMolecules (Basel, Switzerland)2026

α-Synuclein-Targeted Immunotherapies in Parkinson's Disease: In Silico, In Vitro and Clinical Perspectives.

Tatiane B Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.